Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28891048

Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer

Author
HUSSAIN, Maha1 ; CARDUCCI, Michael A2 ; ALUMKAL, Joshi J6 ; SLOVIN, Susan3 ; CETNAR, Jeremy4 ; JIANG QIAN5 ; MCKEEGAN, Evelyn M5 ; REFICI-BUHR, Marion5 ; CHYLA, Brenda5 ; SHEPHERD, Stacie P5 ; GIRANDA, Vincent L5
[1] Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, United States
[2] Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, United States
[3] Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, United States
[4] Department of Medicine, Carbone Cancer Center, University of Wisconsin, Madison, WI, United States
[5] AbbVie Inc, North Chicago, IL, United States
[6] Knight Cancer Institute, Oregon Health & Science University, Portland, OR, United States
Source

Investigational new drugs. 2014, Vol 32, Num 5, pp 904-912, 9 p ; ref : 41 ref

CODEN
INNDDK
ISSN
0167-6997
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
Springer, New York, NY
Publication country
United States
Document type
Article
Language
English
Author keyword
Combination therapy Metastatic castration-resistantprostate cancer Pilot study Temozolomide Veliparib
Keyword (fr)
Anticancéreux Cancer de la prostate Castration Ciblage Cible DNA Homme Métastase Résistance Stade avancé Traitement associé Tumeur maligne Témozolomide Réparation DNA Véliparib Agent alkylant Cancer Dérivé du benzimidazole Pathologie de l'appareil génital mâle Pathologie de l'appareil urinaire Pathologie de la prostate
Keyword (en)
Antineoplastic agent Prostate cancer Castration Targeting Target DNA Human Metastasis Resistance Advanced stage Combined treatment Malignant tumor Temozolomide DNA repair Veliparib Alkylating agent Cancer Benzimidazole derivatives Male genital diseases Urinary system disease Prostate disease
Keyword (es)
Anticanceroso Cáncer de la próstata Castración Blancado Blanco DNA Hombre Metástasis Resistencia Estadio avanzado Tratamiento asociado Tumor maligno Temozolomida Veliparib Agente alquilante Cáncer Benzimidazol derivado Aparato genital macho patología Aparato urinario patología Prostata patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04C Multiple tumors. Solid tumors. Tumors in childhood (general aspects)

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14D Tumors of the urinary system / 002B14D02 Urinary tract. Prostate gland

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B20 Gynecology. Andrology. Obstetrics / 002B20B Male genital diseases / 002B20B02 Tumors

Discipline
Gynecology. Andrology. Obstetrics Nephrology. Urinary tract diseases Pharmacological treatments Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
28891048

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web